A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
Clinical trial NCT01829971 · TERMINATED
Trial details
- NCT number
- NCT01829971
- Sponsor
- Mirna Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2017-03-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.